LISATA THERAPEUTICS - TERMINATES KRISTEN K. BUCK AS EVP OF R&D AND CHIEF MEDICAL OFFICER EFFECTIVE AUG 3, 2026 - SEC FILING

Reuters · 08/04 10:08

Please log in to view news